Loading clinical trials...
Loading clinical trials...
A Global, Phase 1/2, Open Label, Dose Escalation Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
Conditions
Interventions
mRNA-3704
Start Date
May 28, 2019
Primary Completion Date
August 18, 2020
Completion Date
August 18, 2020
Last Updated
November 13, 2020
NCT05778877
NCT00092820
NCT05123768
NCT04645498
NCT01963650
Lead Sponsor
ModernaTX, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions